Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs
Author:
Funder
Gilead Sciences
Boston Scientific Corporation
Abbott Laboratories
Medtronic
Biotronik
Publisher
Elsevier BV
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference28 articles.
1. Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials;Wells;CMAJ,2011
2. Evaluation, management, and outcomes of patients poorly responsive to cardiac resynchronization device therapy;Varma;J Am Coll Cardiol,2019
3. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial;Anand;Circulation,2009
4. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT;Goldenberg;J Am Coll Cardiol,2011
5. Heart Disease and Stroke Statistics—2020 update: a report from the American Heart Association;Virani;Circulation,2020
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ongoing and future clinical trials of device therapies for patients with heart failure;Current Problems in Cardiology;2024-11
2. Atrioventricular optimization improves cardiac resynchronization response in patients with long interventricular electrical delays: A pooled analysis of the SMART-AV and SMART-CRT trials;Heart Rhythm;2024-09
3. CMR feature tracking–based left atrial mechanics predicts response to cardiac resynchronization therapy and adverse outcomes;Heart Rhythm;2024-08
4. Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-blinded CRUSTY trial;Heart Rhythm;2024-06
5. Left ventricular lead placement in cardiac resynchronization therapy: Current data and potential explanations for the lack of benefit;Heart Rhythm;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3